Literature DB >> 7590660

Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis.

O Le Moine1, A Marchant, D De Groote, C Azar, M Goldman, J Devière.   

Abstract

Monocytes of patients with alcoholic cirrhosis produce higher amounts of tumor necrosis factor-alpha (TNF-alpha) after lipopolysaccharide (LPS) stimulation. The mechanisms of the overproduction remain undefined. IL-10 (IL-10) is an antiinflammatory cytokine known to downregulate TNF-alpha secretion by monocytes. The present study analyzes IL-10 production by monocytes and its control on TNF-alpha secretion in alcoholic cirrhosis. LPS-stimulated monocytes from alcoholic cirrhotics (n = 13) showed decreased IL-10 (median, 240 pg/mL [40 to 500] upsilon 513 pg/mL [152 to 1,335]; P = .01) compared with controls (n = 13). Cells from cirrhotic patients were normally responsive to recombinant IL-10, which induced a dose dependent decrease of TNF-alpha secretion. On the other hand, preincubation with anti-IL-10 monoclonal antibodies led to significant increase in TNF-alpha secretion in controls (median, 7,325 to 16,800 pg/mL; P = .002) but not in cells from cirrhotic patients (16,535 to 20,450 pg/mL; P = .14), abolishing the difference in TNF-alpha production between cirrhotic patients and controls. It is concluded that defective IL-10 secretion by monocytes from alcoholic cirrhotic patients could be involved in the characteristics TNF-alpha overproduction observed in this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590660

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  24 in total

Review 1.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 2.  Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.

Authors:  Mack C Mitchell; Lawrence S Friedman; Craig J McClain
Journal:  Clin Gastroenterol Hepatol       Date:  2017-01       Impact factor: 11.382

Review 3.  Spontaneous bacterial peritonitis: from pathophysiology to prevention.

Authors:  Mauro Bernardi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

4.  HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.

Authors:  J F Schlaak; G Tully; H F Löhr; G Gerken; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 5.  Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway.

Authors:  Palash Mandal; Michele T Pritchard; Laura E Nagy
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

Review 6.  Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development.

Authors:  H Joe Wang; Samir Zakhari; M Katherine Jung
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

7.  The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells.

Authors:  Palash Mandal; Pil-Hoon Park; Megan R McMullen; Brian T Pratt; Laura E Nagy
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

8.  Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat.

Authors:  A Kaviani; M Ohta; R Itani; F Sander; A S Tarnawski; I J Sarfeh
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

Review 9.  Advances in alcoholic liver disease.

Authors:  Zhenyuan Song; Swati Joshi-Barve; Shrish Barve; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2004-02

10.  Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll-like receptor 9 activation.

Authors:  B Massonnet; A Delwail; J-M Ayrault; C Chagneau-Derrode; J-C Lecron; C Silvain
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.